Extensive scope of immuno-oncology agents in various cancer treatments would provide maximum share to immuno-oncology treatment in overall cancer drug market during the forecast period. This lucrative opportunities in immuno-oncology treatment would provide boost to the product development during the forecast period. The slower pace of research and development activities and capital intense investment in manufacturing are the factors extending the commercialization of immuno-oncology therapies. However, lesser side effects associated with immunological treatments and better efficacy is expecting to get positive response from the cancer specialists after commercialization of immuno-oncology therapies.
Geographically, the global Immuno-oncology therapies market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America and Europe are the lucrative regions for immuno-oncology market due to their potential to invest the huge amount of money in the development of immuno-oncology therapies and availability of better reimbursement policies. Moreover, affordability for the cost of treatment is also high in North America and Europe. The global immuno-oncology market is expected to grow during the forecast period due to increasing investment by multinational companies in the cancer research
Some of the key players in global immuno-oncology market are Seattle Genetics, Inc., Genentech, Inc., F. Hoffmann-La Roche Ltd., Eisai Co. Ltd., Amgen Inc., Bayer AG, Sanofi Aventis LLC., Merck & Co., Inc., Bristol-Myers Squibb Company, Dendreon Corporation and others. The global immuno-oncology market is expected to grow during the forecast period due to increasing investment by multinational companies in the cancer research.
Request for Table of Content@ http://www.persistencemarketresearch.com/toc/11329
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353